Lymont
Brand Name: Lymont
Generic Name: Montelukast (as sodium)+ Levocetirizine Hydrochloride
Active
Registration Number
DRP-12622-03
Dosage Form
Film-Coated Tablet
Issuance Date
January 31, 2023
Expiry Date
June 29, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength10mg/5mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Leukotriene Receptor Antagonist/Antihistamine
A
Application
CLIDP Conversion
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
Montelukast (as sodium)Active
Monograph: repurposed montelukast
Levocetirizine HydrochlorideActive
Monograph: Levocetirizine